Mettler-Toledo International Inc.

DB:MTO Stock Report

Market Cap: €25.2b

Mettler-Toledo International Valuation

Is MTO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MTO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MTO (€1183) is trading below our estimate of fair value (€1453.11)

Significantly Below Fair Value: MTO is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MTO?

Key metric: As MTO is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MTO. This is calculated by dividing MTO's market cap by their current earnings.
What is MTO's PE Ratio?
PE Ratio32.4x
EarningsUS$795.63m
Market CapUS$25.82b

Price to Earnings Ratio vs Peers

How does MTO's PE Ratio compare to its peers?

The above table shows the PE ratio for MTO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average65x
SRT3 Sartorius
191.4x30.5%€13.4b
1SXP SCHOTT Pharma KGaA
24.9x15.7%€3.7b
GXI Gerresheimer
21.2x21.8%€2.4b
MRK Merck KGaA
22.6x10.3%€61.0b
MTO Mettler-Toledo International
32.4x7.3%€25.8b

Price-To-Earnings vs Peers: MTO is good value based on its Price-To-Earnings Ratio (32.4x) compared to the peer average (65x).

Price to Earnings Ratio vs Industry

How does MTO's PE Ratio compare vs other companies in the European Life Sciences Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
MTO 32.4xIndustry Avg. 38.2xNo. of Companies3PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: MTO is good value based on its Price-To-Earnings Ratio (32.4x) compared to the European Life Sciences industry average (38.2x).

Price to Earnings Ratio vs Fair Ratio

What is MTO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MTO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio32.4x
Fair PE Ratio19.1x

Price-To-Earnings vs Fair Ratio: MTO is expensive based on its Price-To-Earnings Ratio (32.4x) compared to the estimated Fair Price-To-Earnings Ratio (19.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MTO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1,183.00
€1,306.11
+10.4%
8.4%€1,461.60€1,120.56n/a12
Dec ’25€1,175.00
€1,266.84
+7.8%
8.4%€1,431.00€1,120.95n/a12
Nov ’25€1,181.50
€1,251.45
+5.9%
9.9%€1,448.32€1,086.24n/a12
Oct ’25€1,339.50
€1,247.08
-6.9%
9.6%€1,427.37€1,084.08n/a12
Sep ’25€1,287.50
€1,235.65
-4.0%
9.2%€1,412.68€1,072.92n/a12
Aug ’25€1,401.00
€1,261.74
-9.9%
9.7%€1,468.84€1,108.56n/a11
Jul ’25€1,295.00
€1,255.05
-3.1%
10.8%€1,477.27€1,068.47n/a11
Jun ’25€1,278.00
€1,220.86
-4.5%
15.6%€1,473.93€815.76n/a10
May ’25€1,167.00
€1,115.98
-4.4%
12.3%€1,276.77€826.14n/a11
Apr ’25€1,232.00
€1,088.42
-11.7%
12.0%€1,256.78€813.21n/a11
Mar ’25€1,150.00
€1,088.42
-5.4%
12.0%€1,256.78€813.21n/a11
Feb ’25€1,104.00
€1,059.98
-4.0%
14.2%€1,377.01€812.50n/a11
Jan ’25€1,104.00
€1,027.02
-7.0%
14.8%€1,366.12€806.08€1,177.0012
Dec ’24€997.00
€1,024.32
+2.7%
13.6%€1,333.28€809.16€1,175.0012
Nov ’24€927.00
€1,165.69
+25.7%
16.1%€1,426.39€825.26€1,181.5012
Oct ’24€1,054.00
€1,200.55
+13.9%
12.5%€1,379.70€798.25€1,339.5012
Sep ’24€1,116.00
€1,200.55
+7.6%
12.5%€1,379.70€798.25€1,287.5012
Aug ’24€1,138.00
€1,200.55
+5.5%
12.5%€1,379.70€798.25€1,401.0012
Jul ’24€1,206.00
€1,347.32
+11.7%
13.1%€1,542.80€817.87€1,295.0012
Jun ’24€1,236.00
€1,347.32
+9.0%
13.1%€1,542.80€817.87€1,278.0012
May ’24€1,320.00
€1,357.19
+2.8%
14.9%€1,539.35€751.57€1,167.0012
Apr ’24€1,372.50
€1,384.90
+0.9%
14.5%€1,585.59€774.14€1,232.0012
Mar ’24€1,345.50
€1,384.90
+2.9%
14.5%€1,585.59€774.14€1,150.0012
Feb ’24€1,404.00
€1,284.10
-8.5%
15.5%€1,565.70€764.43€1,104.0012
Jan ’24€1,370.00
€1,243.40
-9.2%
12.7%€1,415.10€783.02€1,104.0012

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 08:23
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mettler-Toledo International Inc. is covered by 32 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Ishan MajumdarBaptista Research
Derik de BruinBofA Global Research